Alistair Milnes Bicycle Therapeutics PLC (BCYC) insider trading activity

Alistair Milnes is CHIEF OPERATING OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 93,377 shares of BCYC, which is worth approximately $605,082. The most recent transaction as insider was on Oct 03, 2025, when has been sold 978 shares (Ordinary Shares) at a price of $8.41 per share, resulting in proceeds of $8,224. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.4K

2.23% 3M change

32.82% 12M change

Total Value Held $605,082

Alistair Milnes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2025	SELL Open market or private sale	$8,224 $8.41 p/Share	978 Reduced 1.04%	93,377 Ordinary Shares
Oct 02 2025	SELL Open market or private sale	$9,634 $8.4 p/Share	1,147 Reduced 1.2%	94,355 Ordinary Shares
Jul 03 2025	SELL Open market or private sale	$7,187 $7.44 p/Share	966 Reduced 1.0%	95,502 Ordinary Shares
Jul 02 2025	SELL Open market or private sale	$8,146 $7.09 p/Share	1,149 Reduced 1.18%	96,468 Ordinary Shares
Apr 03 2025	SELL Open market or private sale	$7,764 $7.48 p/Share	1,038 Reduced 1.05%	97,617 Ordinary Shares
Apr 02 2025	SELL Open market or private sale	$9,086 $8.02 p/Share	1,133 Reduced 1.14%	98,655 Ordinary Shares
Jan 03 2025	SELL Open market or private sale	$13,806 $14.75 p/Share	936 Reduced 0.93%	99,788 Ordinary Shares

Jan 02 2025	SELL Open market or private sale	$64,504 $14.09 p/Share	4,578 Reduced 4.35%	100,724 Ordinary Shares
Jan 02 2025	BUY Grant, award, or other acquisition	-	35,000 Added 24.95%	105,302 Ordinary Shares
Oct 03 2024	SELL Open market or private sale	$21,636 $22.26 p/Share	972 Reduced 1.36%	70,302 Ordinary Shares
Jul 03 2024	SELL Open market or private sale	$18,991 $19.64 p/Share	967 Reduced 1.34%	71,274 Ordinary Shares
Apr 03 2024	SELL Open market or private sale	$22,738 $23.81 p/Share	955 Reduced 1.3%	72,241 Ordinary Shares
Jan 03 2024	SELL Open market or private sale	$46,252 $17.5 p/Share	2,643 Reduced 3.49%	73,196 Ordinary Shares
Jan 02 2024	BUY Grant, award, or other acquisition	-	39,000 Added 33.96%	75,839 Ordinary Shares
Oct 03 2023	SELL Open market or private sale	$8,840 $20.0 p/Share	442 Reduced 1.19%	36,839 Ordinary Shares
Jul 03 2023	SELL Open market or private sale	$11,320 $25.1 p/Share	451 Reduced 1.2%	37,281 Ordinary Shares
Apr 03 2023	SELL Open market or private sale	$9,436 $21.11 p/Share	447 Reduced 1.17%	37,732 Ordinary Shares
Jan 03 2023	SELL Open market or private sale	$52,337 $29.06 p/Share	1,801 Reduced 4.5%	38,179 Ordinary Shares
Jan 03 2023	BUY Grant, award, or other acquisition	-	17,500 Added 30.45%	39,980 Ordinary Shares
Mar 25 2022	BUY Exercise of conversion of derivative security	$103,719 $20.12 p/Share	5,155 Added 18.65%	22,480 Ordinary Shares
Jan 03 2022	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Ordinary Shares

Also insider at

FEMY

FEMASYS INC Healthcare

Alistair Milnes

CHIEF OPERATING OFFICER

Cambridge, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Value

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC

Account